Dyadic International, Inc.
General ticker "DYAI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $29.0M (TTM average)
Dyadic International, Inc. does not follow the US Stock Market performance with the rate: -10.8%.
Estimated limits based on current volatility of 6.2%: low 0.69$, high 0.78$
Factors to consider:
- Total employees count: 7 as of 2023
- Top business risk factors: Operational and conduct risks, Regulatory and compliance, Economic downturns and volatility, Market competition, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 1.61$]
- 2026-12-31 to 2027-12-31 estimated range: [0.73$, 1.71$]
Financial Metrics affecting the DYAI estimates:
- Positive: with PPE of -3.8 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 0.27 > -0.60
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 1.48 <= 3.31
Short-term DYAI quotes
Long-term DYAI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.90MM | $3.50MM | $1.23MM |
| Operating Expenses | $11.13MM | $9.40MM | $8.38MM |
| Operating Income | $-8.23MM | $-5.90MM | $-7.15MM |
| Non-Operating Income | $1.43MM | $0.09MM | $-0.22MM |
| Interest Expense | $0.00MM | $0.43MM | $0.46MM |
| R&D Expense | $3.30MM | $2.04MM | $2.15MM |
| Income(Loss) | $-6.80MM | $-5.81MM | $-7.36MM |
| Net Income(Loss)* | $-6.80MM | $-5.81MM | $-7.36MM |
| Stockholders Equity | $5.88MM | $2.47MM | $1.23MM |
| Assets | $8.22MM | $9.93MM | $9.95MM |
| Operating Cash Flow | $-6.73MM | $-3.97MM | $-5.70MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $7.45MM | $-1.88MM | $0.08MM |
| Financing Cash Flow | $0.00MM | $5.85MM | $4.96MM |
| Earnings Per Share** | $-0.24 | $-0.20 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.